Lv5
1130 积分 2025-10-11 加入
Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma
18天前
已完结
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
18天前
已完结
Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study
18天前
已完结
Dual clinical remission in severe asthma and chronic rhinosinusitis with nasal polyps: a comparative review of biologic therapies
25天前
已完结
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma
25天前
已完结
Budesonide–glycopyrronium–formoterol fumarate dihydrate in uncontrolled asthma (KALOS and LOGOS): twin multicentre, double-blind, double-dummy, parallel-group, randomised, phase 3 trials
1个月前
已完结
A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment
1个月前
已完结
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma
1个月前
已完结
Role of IL‐5 in asthma and airway remodelling
1个月前
已完结
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
1个月前
已完结
皖公网安备34019202002308
